Immune Targeting of Tumor Epithelial-Mesenchymal Transition via Brachyury-Based Vaccines. (Q38555670)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216630%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

review article

1 reference

title

Immune Targeting of Tumor Epithelial-Mesenchymal Transition via Brachyury-Based Vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216630%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Claudia Palena

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216630%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Duane H Hamilton

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216630%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

12 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216630%20AND%20SRC:MED&resulttype=core&format=json

Advances in Cancer Research

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216630%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216630%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

69-93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216630%20AND%20SRC:MED&resulttype=core&format=json

Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients

20 February 2020

cites work

1 reference

12 December 2020

Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]

1 reference

12 December 2020

The Hallmarks of Cancer

1 reference

12 December 2020

The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression

1 reference

12 December 2020

Stem cells, cancer, and cancer stem cells

1 reference

12 December 2020

Immune escape of tumors: apoptosis resistance and tumor counterattack.

1 reference

12 December 2020

Correlation of Snail expression with histological grade and lymph node status in breast carcinomas

1 reference

12 December 2020

Epithelial-mesenchymal transitions in tumour progression

1 reference

12 December 2020

The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors

1 reference

12 December 2020

Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals

1 reference

12 December 2020

Epithelial-mesenchymal transitions in development and pathologies

1 reference

12 December 2020

Snail blocks the cell cycle and confers resistance to cell death

1 reference

12 December 2020

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

1 reference

12 December 2020

MVA as a vector for vaccines against HIV-1.

1 reference

12 December 2020

Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition

1 reference

12 December 2020

Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target

1 reference

12 December 2020

A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers.

1 reference

12 December 2020

Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition

1 reference

12 December 2020

Ectopic mesoderm formation in Xenopus embryos caused by widespread expression of a Brachyury homologue.

1 reference

12 December 2020

Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas

1 reference

12 December 2020

Mechanisms of immune evasion by tumors

1 reference

12 December 2020

Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines

1 reference

12 December 2020

Immunosuppressive strategies that are mediated by tumor cells

1 reference

12 December 2020

The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy.

1 reference

12 December 2020

Genetic determinants of cancer metastasis

1 reference

12 December 2020

Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.

1 reference

12 December 2020

Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition.

1 reference

12 December 2020

Development and characterization of gemcitabine-resistant pancreatic tumor cells.

1 reference

12 December 2020

Twist expression in patients with cervical cancer is associated with poor disease outcome

1 reference

12 December 2020

Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells

1 reference

12 December 2020

Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue

1 reference

12 December 2020

The epithelial-mesenchymal transition generates cells with properties of stem cells

1 reference

12 December 2020

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

1 reference

12 December 2020

Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses.

1 reference

12 December 2020

Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation

1 reference

12 December 2020

Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy

1 reference

12 December 2020

Establishment of a normal hematopoietic and leukemia stem cell hierarchy.

1 reference

12 December 2020

Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen

1 reference

12 December 2020

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

1 reference

12 December 2020

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

1 reference

12 December 2020

Metastasis: from dissemination to organ-specific colonization

1 reference

12 December 2020

The basics of epithelial-mesenchymal transition

1 reference

12 December 2020

Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells

1 reference

12 December 2020

Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity

1 reference

12 December 2020

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

1 reference

12 December 2020

Concurrent vaccination with two distinct vaccine platforms targeting the same antigen generates phenotypically and functionally distinct T-cell populations

1 reference

12 December 2020

T (brachyury) gene duplication confers major susceptibility to familial chordoma

1 reference

12 December 2020

Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer

1 reference

12 December 2020

Epithelial-mesenchymal transitions in development and disease

1 reference

12 December 2020

Epithelial-mesenchymal transition in cancer development and its clinical significance

1 reference

12 December 2020

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

1 reference

12 December 2020

The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells

1 reference

12 December 2020

Vaccines against human carcinomas: strategies to improve antitumor immune responses

1 reference

12 December 2020

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

12 December 2020

Brachyury expression predicts poor prognosis at early stages of colorectal cancer

1 reference

12 December 2020

Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells

1 reference

12 December 2020

Maturation of human dendritic cells with Saccharomyces cerevisiae (yeast) reduces the number and function of regulatory T cells and enhances the ratio of antigen-specific effectors to regulatory T cells

1 reference

12 December 2020

IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells

1 reference

12 December 2020

Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells?

1 reference

12 December 2020

Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer

1 reference

12 December 2020

Viral vector-based therapeutic cancer vaccines

1 reference

12 December 2020

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

1 reference

12 December 2020

Expression of tumour-specific antigens underlies cancer immunoediting

1 reference

12 December 2020

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

1 reference

12 December 2020

Vaccination against pox diseases under immunosuppressive conditions

1 reference

12 December 2020

Therapeutic cancer vaccines: current status and moving forward

1 reference

12 December 2020

Expression of brachyury in hemangioblastoma: potential use in differential diagnosis.

1 reference

12 December 2020

Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links

1 reference

12 December 2020

Clinical evaluation of TRICOM vector therapeutic cancer vaccines

1 reference

12 December 2020

Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas

1 reference

12 December 2020

Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer

1 reference

12 December 2020

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

12 December 2020

Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment

1 reference

12 December 2020

An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance

1 reference

12 December 2020

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

1 reference

12 December 2020

Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis.

1 reference

12 December 2020

Expression of Brachyury gene is a significant prognostic factor for primary lung carcinoma.

1 reference

12 December 2020

EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy induction

1 reference

12 December 2020

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

1 reference

12 December 2020

An autocrine loop between TGF-β1 and the transcription factor brachyury controls the transition of human carcinoma cells into a mesenchymal phenotype

1 reference

12 December 2020

The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies

1 reference

12 December 2020

Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer

1 reference

12 December 2020

Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine

1 reference

12 December 2020

An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530).

1 reference

12 December 2020

Epithelial plasticity: a common theme in embryonic and cancer cells.

1 reference

12 December 2020

Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma.

1 reference

12 December 2020

An immunotherapeutic intervention against tumor progression: Targeting a driver of the epithelial-to-mesenchymal transition

1 reference

12 December 2020

WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transition

1 reference

12 December 2020

PhenoNet: identification of key networks associated with disease phenotype

1 reference

12 December 2020

Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.

1 reference

12 December 2020

Therapeutic cancer vaccines.

1 reference

12 December 2020

T-box transcription factor brachyury is associated with prostate cancer progression and aggressiveness.

1 reference

12 December 2020

Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation.

1 reference

12 December 2020

AXL inhibition sensitizes mesenchymal cancer cells to antimitotic drugs

1 reference

12 December 2020

Therapeutic vaccines as a promising treatment modality against prostate cancer: rationale and recent advances

1 reference

12 December 2020

Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis

1 reference

12 December 2020

Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.

1 reference

12 December 2020

The network of epithelial-mesenchymal transition: potential new targets for tumor resistance

1 reference

12 December 2020

Mechanism of action of immunotherapy

1 reference

12 December 2020

Pancreatic cancer, treatment options, and GI-4000

1 reference

12 December 2020

Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody

1 reference

12 December 2020

The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?

1 reference

12 December 2020

Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins

1 reference

12 December 2020

Phosphorylation of the nuclear lamins during interphase and mitosis

1 reference

12 December 2020

The T protein encoded by Brachyury is a tissue-specific transcription factor

1 reference

12 December 2020

Lamin proteolysis facilitates nuclear events during apoptosis

1 reference

12 December 2020

Crystallographic structure of the T domain-DNA complex of the Brachyury transcription factor

1 reference

12 December 2020

Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine

1 reference

12 December 2020

10.1016/BS.ACR.2015.04.001

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216630%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216630%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

PubMed publication ID

26216630

1 reference